UPGRADES
Alliant Energy (LNT)
Brokerage Firm: Mizuho | Action: Upgrade | Ratings Change: Neutral » Buy | Price Tgt: $50 » $61
Banco Santander Mexico (BSMX)
Brokerage Firm: JP Morgan | Action: Upgrade | Ratings Change: Neutral » Overweight | Price Tgt: $6.50
Cerence (CRNC)
Brokerage Firm: Evercore ISI | Action: Upgrade | Ratings Change: In-line » Outperform | Price Tgt: $125
Gap (GPS)
Brokerage Firm: Credit Suisse | Action: Upgrade | Ratings Change: Underperform » Neutral | Price Tgt: $23
MasterCard (MA)
Brokerage Firm: Daiwa Securities | Action: Upgrade | Ratings Change: Neutral » Outperform | Price Tgt: $402
MediaAlpha (MAX)
Brokerage Firm: Citigroup | Action: Upgrade | Ratings Change: Neutral » Buy | Price Tgt: $62 » $45
MGM Resorts (MGM)
Brokerage Firm: JP Morgan | Action: Upgrade | Ratings Change: Neutral » Overweight | Price Tgt: $45 » $47
Palo Alto Networks (PANW)
Brokerage Firm: Raymond James | Action: Upgrade | Ratings Change: Mkt Perform » Outperform | Price Tgt: $400
Snowflake (SNOW)
Brokerage Firm: Rosenblatt | Action: Upgrade | Ratings Change: Neutral » Buy | Price Tgt: $285
Visa (V)
Brokerage Firm: Daiwa Securities | Action: Upgrade | Ratings Change: Neutral » Outperform | Price Tgt: $259
DOWNGRADES
Advent Technologies (ADN)
Brokerage Firm: Goldman | Action: Downgrade | Ratings Change: Buy » Neutral | Price Tgt: $20
Altice USA (ATUS)
Brokerage Firm: BofA Securities | Action: Downgrade | Ratings Change: Neutral » Underperform | Price Tgt: $38
II-VI (IIVI)
Brokerage Firm: Barclays | Action: Downgrade | Ratings Change: Overweight » Equal Weight | Price Tgt: $105 » $65
COVERAGE INITIATED
Adicet Bio (ACET)
Brokerage Firm: BTIG Research | Action: Initiated | Ratings Change: Buy | Price Tgt: $34
Agiliti (AGTI)
Brokerage Firm: Jefferies | Action: Initiated | Ratings Change: Buy | Price Tgt: $20
Agiliti (AGTI)
Brokerage Firm: BofA Securities | Action: Initiated | Ratings Change: Buy | Price Tgt: $18
Agiliti (AGTI)
Brokerage Firm: KeyBanc Capital Markets | Action: Initiated | Ratings Change: Overweight | Price Tgt: $21
Agiliti (AGTI)
Brokerage Firm: Morgan Stanley | Action: Initiated | Ratings Change: Overweight | Price Tgt: $21
Agiliti (AGTI)
Brokerage Firm: BMO Capital Markets | Action: Initiated | Ratings Change: Outperform | Price Tgt: $18
Agiliti (AGTI)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Buy | Price Tgt: $43
Agiliti (AGTI)
Brokerage Firm: UBS | Action: Initiated | Ratings Change: Neutral | Price Tgt: $16
Agiliti (AGTI)
Brokerage Firm: Citigroup | Action: Initiated | Ratings Change: Buy | Price Tgt: $19
Allakos (ALLK)
Brokerage Firm: H.C. Wainwright | Action: Initiated | Ratings Change: Buy | Price Tgt: $230
Arena Pharm (ARNA)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Buy | Price Tgt: $90
BioNTech (BNTX)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Neutral | Price Tgt: $173
CASI Pharma (CASI)
Brokerage Firm: BTIG Research | Action: Initiated | Ratings Change: Buy | Price Tgt: $4
Denali Therapeutics (DNLI)
Brokerage Firm: UBS | Action: Initiated | Ratings Change: Buy | Price Tgt: $70
InMode (INMD)
Brokerage Firm: Needham | Action: Initiated | Ratings Change: Buy | Price Tgt: $94
Latham Group (SWIM)
Brokerage Firm: Robert W. Baird | Action: Initiated | Ratings Change: Outperform | Price Tgt: $36
Latham Group (SWIM)
Brokerage Firm: Morgan Stanley | Action: Initiated | Ratings Change: Equal-Weight | Price Tgt: $33
Latham Group (SWIM)
Brokerage Firm: KeyBanc Capital Markets | Action: Initiated | Ratings Change: Overweight | Price Tgt: $38
Latham Group (SWIM)
Brokerage Firm: William Blair | Action: Initiated | Ratings Change: Outperform | Price Tgt: —
Latham Group (SWIM)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Neutral | Price Tgt: $26
Latham Group (SWIM)
Brokerage Firm: Truist | Action: Initiated | Ratings Change: Buy | Price Tgt: —
Latham Group (SWIM)
Brokerage Firm: Barclays | Action: Initiated | Ratings Change: Overweight | Price Tgt: $37
Legend Biotech (LEGN)
Brokerage Firm: BTIG Research | Action: Initiated | Ratings Change: Buy | Price Tgt: $55
Magenta Therapeutics (MGTA)
Brokerage Firm: B. Riley Securities | Action: Initiated | Ratings Change: Buy | Price Tgt: $21
Mustang Bio (MBIO)
Brokerage Firm: BTIG Research | Action: Initiated | Ratings Change: Buy | Price Tgt: $11
Onconova Therapeutics (ONTX)
Brokerage Firm: Guggenheim | Action: Initiated | Ratings Change: Buy | Price Tgt: $4
Pool (POOL)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Buy | Price Tgt: $535
Poseida Therapeutics (PSTX)
Brokerage Firm: BTIG Research | Action: Initiated | Ratings Change: Buy | Price Tgt: $40
Rain Therapeutics (RAIN)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Buy | Price Tgt: $56
Rain Therapeutics (RAIN)
Brokerage Firm: Piper Sandler | Action: Initiated | Ratings Change: Overweight | Price Tgt: $25
Rain Therapeutics (RAIN)
Brokerage Firm: Guggenheim | Action: Initiated | Ratings Change: Buy | Price Tgt: $26
Rain Therapeutics (RAIN)
Brokerage Firm: Citigroup | Action: Initiated | Ratings Change: Buy | Price Tgt: $28
Revolution Medicines (RVMD)
Brokerage Firm: Goldman | Action: Initiated | Ratings Change: Buy | Price Tgt: $49
Stoke Therapeutics (STOK)
Brokerage Firm: UBS | Action: Initiated | Ratings Change: Neutral | Price Tgt: $35
Surface Oncology (SURF)
Brokerage Firm: BTIG Research | Action: Initiated | Ratings Change: Buy | Price Tgt: $17
Treace Medical Concepts (TMCI)
Brokerage Firm: Stifel | Action: Initiated | Ratings Change: Buy | Price Tgt: $35
Treace Medical Concepts (TMCI)
Brokerage Firm: Morgan Stanley | Action: Initiated | Ratings Change: Equal-Weight | Price Tgt: $30
Treace Medical Concepts (TMCI)
Brokerage Firm: JP Morgan | Action: Initiated | Ratings Change: Overweight | Price Tgt: $37
TS Innovation Acquisitions (TSIA)
Brokerage Firm: The Benchmark Company | Action: Initiated | Ratings Change: Buy | Price Tgt: $16
Vascular Biogenics (VBLT)
Brokerage Firm: Guggenheim | Action: Initiated | Ratings Change: Buy | Price Tgt: $7
COVERAGE RESUMED
Coherent (COHR)
Brokerage Firm: Barclays | Action: Resumed | Ratings Change: Equal Weight | Price Tgt: $250
Exelixis (EXEL)
Brokerage Firm: Goldman | Action: Resumed | Ratings Change: Sell | Price Tgt: $23
Lumentum (LITE)
Brokerage Firm: Barclays | Action: Resumed | Ratings Change: Overweight | Price Tgt: $85
Marathon Petroleum (MPC)
Brokerage Firm: Credit Suisse | Action: Resumed | Ratings Change: Outperform | Price Tgt: $74
Nektar Therapeutics (NKTR)
Brokerage Firm: Goldman | Action: Resumed | Ratings Change: Neutral | Price Tgt: $24
Neurocrine Biosci (NBIX)
Brokerage Firm: Goldman | Action: Resumed | Ratings Change: Neutral | Price Tgt: $108
Seres Therapeutics (MCRB)
Brokerage Firm: Goldman | Action: Resumed | Ratings Change: Neutral | Price Tgt: $24